Literature DB >> 9248871

Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium.

J Nakamura1, N Uchimura, S Yamada, Y Nakazawa.   

Abstract

Sixty-six patients (47 men, 19 women, mean age 65 years) with delirium were treated with mianserin (10-60 mg/day) or haloperidol (2-6 mg/day) at Kurume University Hospital. The clinical effects of these drugs were compared before and after treatment using the Delirium Rating Scale. At the same time, blood was sampled to analyse plasma mianserin, free-3-methoxy-4-hydroxyphenyl(ethylene)glycol (MHPG) and homovanillic acid concentrations. Marked improvement after 1 week was observed in 69.4% of patients undergoing mianserin treatment, and in 70.6% of those receiving haloperidol. A statistically significant difference in the clinical effects of these drugs was not observed. Although improvement in the delirious state and a decrease in the plasma free-MHPG concentration were observed after drug administration, the plasma free-homovanillic acid concentration showed no significant change. The higher plasma free-MHPG concentration in the delirious state suggests the existence of a preparatory state whereby noradrenaline metabolism is involved in the appearance of the abnormal behaviour associated with delirium. These data suggest that free-MHPG concentrations could potentially be used as a predictor of delirium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248871     DOI: 10.1097/00004850-199705000-00005

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  11 in total

Review 1.  Delirium: optimising management.

Authors:  D J Meagher
Journal:  BMJ       Date:  2001-01-20

2.  Optimising management of delirium. Placebo controlled trials of pharmacological treatments are needed.

Authors:  C J Ryan
Journal:  BMJ       Date:  2001-06-30

3.  Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".

Authors:  Theodore A Stern; Anne F Gross; Thomas W Stern; Shamim H Nejad; Jose R Maldonado
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 4.  Delirium and its treatment.

Authors:  Azizah Attard; Gopinath Ranjith; David Taylor
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  Delirium.

Authors:  A Burns; A Gallagley; J Byrne
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

Review 6.  Antipsychotics for treatment of delirium in hospitalised non-ICU patients.

Authors:  Lisa Burry; Sangeeta Mehta; Marc M Perreault; Jay S Luxenberg; Najma Siddiqi; Brian Hutton; Dean A Fergusson; Chaim Bell; Louise Rose
Journal:  Cochrane Database Syst Rev       Date:  2018-06-18

7.  Post-operative delirium after hip fracture treatment - a review of the current literature.

Authors:  Theocharis Chr Kyziridis
Journal:  Psychosoc Med       Date:  2006-02-08

8.  Effects of dexmedetomidine on smooth emergence from anaesthesia in elderly patients undergoing orthopaedic surgery.

Authors:  Dong Jun Kim; Sang Hun Kim; Keum Young So; Ki Tae Jung
Journal:  BMC Anesthesiol       Date:  2015-10-07       Impact factor: 2.217

9.  Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial.

Authors:  Edmée J M Schrijver; Oscar J de Vries; Astrid Verburg; Karola de Graaf; Pierre M Bet; Peter M van de Ven; Ad M Kamper; Sabine Ha Diepeveen; Sander Anten; Andrea Siegel; Esther Kuipéri; Anne M Lagaay; Rob J van Marum; Astrid M van Strien; Leo Boelaarts; Douwe Pons; Mark H H Kramer; Prabath W B Nanayakkara
Journal:  BMC Geriatr       Date:  2014-08-28       Impact factor: 3.921

10.  Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report.

Authors:  Sho Horikoshi; Itaru Miura; Yasuto Kunii; Satoko Asano; Keiko Kanno-Nozaki; Hirobumi Mashiko; Hirooki Yabe
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.